PYCARD and polycystic ovary syndrome: Overall, PYCARD mRNA levels in SAT and VAT combined were lower in the PCOS group (number of biopsies = 15) compared to the non-PCOS group (number of biopsies = 15), although the difference was not statistically significant (median [IQR], 0.5471 [0.04671–2.101] vs. 1.633 [1.132–1.880], p = 0.226, respectively).